-
Product Insights
Barra Dos Coqueiros
Barra Dos Coqueiros is a Hydro project located in Goias, Brazil. The project is owned by Gerdau Acos Longos S/A. and was developed by CESBE SA; Gerdau SA; Toniolo Busnello SA. The project came online in 2010. Empower your strategies with our Barra Dos Coqueiros report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
Cacu
Cacu is a Hydro project located in Goias, Brazil. The project is owned by Gerdau Acos Longos S/A. and was developed by CESBE SA; Gerdau SA. The project came online in 2010. Empower your strategies with our Cacu report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Company Profile
Empire Co Ltd – Company Profile
Empire Co Ltd (Empire) is a food retailer and real estate service provider. The company operates food retail stores, wholesale, pharmacies, convenience stores, health care, liquor stores and fuel stations in Canada. Its product portfolio includes deli, seafood, meat, bakery products, grocery products, healthcare products, prepared foods, farm-fresh products, liquor and fuel. Empire offers products under various banners such as Sobeys, Fresh Co, Sobeys West, Thrifty Foods, Foodland, Lawtons Drugs, FastFuel, Compliments, Marche Bonichoix, Panache, and Safeway. It offers products...
Add to Basket -
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...